$0.17
(0.91%)
Add to watchlist
Create an alert
Stocks and Shares ISATakeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Company Information
About this company
Key people
Masami Iijima
Chairman of Board of Directors, Independent Director
Christophe P. Weber
President, Chief Executive Officer, Representative Director
Milano Furuta
Chief Financial Officer, Director
Andrew S. Plump
President of Research & Development, Director
Jean-Luc Butel
Independent Director
Ian T. Clark
Independent Director
Yoshiaki Fujimori
Independent Director
Steven H. Gillis
Independent Director
Click to see more
Key facts
- Shares in issue1.59bn
- EPICTAK
- ISINUS8740602052
- LocationJapan
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$57.77bn
- Employees47,455
- ExchangeNew York Stock Exchange
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.